PBMWW
Psyence Biomedical Ltd. WarrantKey Statistics
About Psyence Biomedical Ltd. Warrant
Psyence Biomedical Ltd. is a leading innovator in the psychedelic biopharmaceutical industry, dedicated to developing psilocybin-based therapies for pressing mental health conditions such as anxiety and depression. The company combines robust scientific research with strict regulatory compliance, enabling it to strategically navigate the shifting perceptions and regulatory frameworks surrounding psychedelics. With a comprehensive intellectual property portfolio and a commitment to advancing mental health treatment, Psyence is well-positioned to capitalize on the burgeoning market for alternative therapies and deliver groundbreaking clinical solutions based on the therapeutic potential of psychedelics.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-6.23M |
| Operating Margin | 0.00% |
| Return on Equity | -58.60% |
| Return on Assets | -31.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $7.39 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $2.61M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on PBMWW and any ticker you trade — then tracks every position and per-strategy win rate.